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Letter to the EditorEnhanced Pru p 3 IgE-binding activ-
ity by selective free fatty acid-
interactionFIG 1. Pru p 3 displays differential ligand binding. Concentration-
dependent reduction in ANS binding to Pru p 3 preincubated with FFA.
Positive control: natural Pru p 3; Negative control: FFA. ELA, Elaidic acid;
FFA, free fatty acid; HYD, 16-hydroxypalmitic acid; LAU, lauric acid; LIN, li-
noleic acid; PAL, palmitic acid.To the Editor:
Nonspecific lipid transfer proteins (nsLTPs) are major cross-
reactive allergens identified in most plant-derived foods as well as
pollen from diverse plants, and are often associated with severe
symptoms in food allergy.1 Currently, Pru p 3 (major food
allergen from peach [Prunus persica]) is regarded as the primary
sensitizer for nsLTP-caused allergies.2 Pru p 3 shares the physico-
chemical characteristics of the nsLTP family. It is a small
(9187 Da) basic protein, with a highly conserved 3-dimensional
structure provided by 8 conserved cysteine residues forming 4 di-
sulfide bridges. The common feature of nsLTPs is a hydrophobic
cavity throughout the whole molecule that can host ligands such
as fatty acids. However, this lipid-binding capacity varies among
different nsLTP members, and depends on the specific character-
istics of their tertiary fold as revised by Liu et al.3 There is limited
knowledge about the binding capacity of Pru p 3. So far, interac-
tions with lauric acid,4 cis-parinaric, palmitic, and linoleic acids5
have been reported. Several structures of nsLTPswith andwithout
ligands have been determined including peach4 and hazelnut6 and
suggested a plasticity of the cavity when binding to ligands as
compared with an unliganded molecule. However, whether the
apo- or holoform of Pru p 3 has an impact on the IgE-binding ac-
tivity is yet unknown. Therefore, we studied a range of saturated
and mono-/poly-unsaturated fatty acids and their interaction with
Pru p 3 and investigated whether Pru p 3-ligand interaction is able
to affect IgE recognition in sera from peach-allergic patients. To
address this question, we first performed nuclear magnetic reso-
nance (NMR) experiments andmolecular dynamic analyses. Sub-
sequently, the IgE-binding activity was investigated by ELISA
and basophil activation test (BAT) assays.
Details formaterials, methods, and patients’ data (Table E1) are
provided in this article’s Online Repository at www.jacionline.
org.
Natural and recombinant Pru p 3 were purified and character-
ized (see Fig E1 in this article’s Online Repository at www.
jacionline.org). Preincubation of Pru p 3 with individual unsatu-
rated and saturated free fatty acids induced a dose-dependent
reduction of 1-anilinonaphthalene-8-sulfonic acid (ANS) bind-
ing. Unsaturated fatty acids induced a larger reduction in ANS
binding compared with saturated fatty acids at all tested concen-
trations (10, 20, 50, and 100 mM). The largest reduction in the
signal was observed for oleic acid (OLE [72.6%]) followed by li-
noleic acid (72%) and elaidic acid (68.6%) at a protein:ligand ra-
tio of 1:10. In contrast, the saturated fatty acid stearic acid (STE)
induced a reduction of 39.1% in ANS binding. In addition, satu-
rated fatty acids with shorter C chains, such as lauric acid (C12),
bind to the internal cavity of Pru p 3more effectively than do satu-
rated fatty acids with longer chains, that is, STE (C18) (Fig 1, A;
see Table E2 in this article’s Online Repository at www.
jacionline.org). 2017 The Authors. Published by Elsevier Inc. on behalf of the American Academy of
Allergy, Asthma & Immunology. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).To support the results from the ANS assay, we decided to
perform water-ligand observed via gradient spectroscopy
(W-LOGSY) experiments, a frequently applied 1-dimensional
ligand-observation NMR technique for the detection of protein-
ligand interactions. W-LOGSY experiments were acquired for
OLE and STE because they showed the highest and the lowest
binding capacity, respectively. NMR experiments confirmed the
binding capacity observed in the ANS assay (see Fig E2 in this
article’s Online Repository at www.jacionline.org). Comparison
of these 2 spectra indicates that recombinant Pru p 3 (rPru p 3)
was able to bind OLE as shown by an inversion of the signal. In
contrast, no interaction of rPru p 3 with STE was detected.
Because pH changes influence the presence of the OLE
protonation state, we decided to investigate whether both OLE
and its anion (OLE2) affect the 3-dimensional structure of Pru p 3.
Molecular dynamic analyses suggest changes in protein structure
due to binding of OLE or OLE2. Binding of OLE2 leads to a
substantial conformational change in the C-terminal fragment
of the protein. Because of the interaction between OLE2 and
Pru p 3, the C-terminal loop is moved out toward the surface of
the molecule, while the same region of Pru p 3 alone is closer to
the core of the molecule (Fig 2, A). These changes are caused by
binding of OLE2 between the thirda-helix (h3) and the C-terminal
loop of Pru p 3, which is stabilized by hydrogen bonds with Arg32
(Fig 2, A). Analysis of intramolecular contacts between Pru p 3 and
OLE2 along the stable part of the molecular dynamic trajectory
(10-150 ns; see Figs E3, A, and E4, A, in this article’s Online
Repository at www.jacionline.org) shows that the ligand interacts
with polar residues on the surface of the protein (Arg32, Asn35,
Arg44) and hydrophobic side chains in the upper part of the
hydrophobic cavity (Ile31, Pro70, Ile77; FigE4,A).This interaction
with OLE2 affects residues 75 to 85, leading to an exposure of
Pro78 and Tyr79 outside the hydrophobic cavity (Fig 2, A). The
Pru p 3-OLE complex has a different structure, as the charge-
neutral ligand immerses almost completely in the hydrophobic
cavity (Figs E3,B, and E4,B) and the key residuesmaking contacts
with the ligand are now Leu10, Ile31, Asn35, Leu51, and Ile81.
OLE penetrates the cavity in a more stretched conformation than
does OLE2, and in consequence, the bottom of the cavity opens
via the movement of helix 3 away from helix 4 (see Figs E4, B,
and E5 in this article’s Online Repository at www.jacionline.org).1
FIG 2. Pru p 3-FFA interaction and impact on the IgE binding. A, Molecular dynamic analysis. Pru p 3 with
OLE2 (upper left); Ca superposition of Pru p 3-apo (blue) and with OLE2 (red). The white ribbon of the Pru p
3-OLE2 complex represents the region affected by the OLE binding (upper right); residues 75 to 80 of Pru p 3
affected by OLE2 binding (lower panel). B, ELISA; data are representative of 10 patients’ sera tested in
triplicate with rPru p 3 alone and with OLE or STE. C, Basophil activation test assay. Percentages of
CD631 basophils after stimulation with allergen at a concentration of 1 ng/mL and an allergen:FFA ratio
of 1:10 in 6 patients sensitized to Pru p 3. The P value refers to the comparison of the median between
allergen alone and in the presence of ligand. FFA, Free fatty acid; ns, nonsignificant. *P <_ .05 (unpaired
2-tailed t test). **P < .01.
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could be important regarding B-cell epitope exposure. Because
the region affected by conformational changes of Pru p 3 is the
one that was identified as the major IgE epitope responsible for
severe reactions,7 we decided to investigate whether conforma-
tional changes due to ligand binding lead to increased IgE-
binding capacity. To test whether interaction of Pru p 3 with
free fatty acids influences its IgE-binding capacity, we used
sera from 10 peach-allergic patients sensitized to Pru p 3. Based
on our results from ANS and W-LOGSY experiments, the 2 li-
gands with highest (OLE) and lowest (STE) binding activity to
Pru p 3 were selected. Preincubation of rPru p 3 with OLE signif-
icantly (P 5 .002) increased the IgE-binding capacity of all sera
tested by ELISA assay when compared with the allergen alone
(Fig 2, B; see Table E3 in this article’s Online Repository at
www.jacionline.org). The largest differences were observed
with sera nos. 2 and 6, with an increase of 118% and 89%, respec-
tively. According to our data, STE did not have a considerable in-
fluence on the IgE-binding capacity of rPru p 3 (P> .05) (Fig 2, B;
Table E3).
Furthermore, we investigated whether the binding of a lipid
ligand also increases the activation of effector cells. Pru p 3
preincubated with OLE significantly increased the number of
CD631 cells as compared with Pru p 3 alone (P5 .031). The per-
centages of CD631 basophils after stimulation with Pru p 3 pre-
incubated with OLE were also significantly (P5 .011) increased
when compared with CD631 basophils after stimulation of Pru p
3 preincubated with STE. In addition, comparison of Pru p 3 pre-
incubated with STE and Pru p 3 alone showed that this ligand did
not have any impact on basophils’ activation (P > .05) (Fig 2, C;
Table E3).
In conclusion, our ligand-binding assays provided interesting
results regarding the binding specificity of Pru p 3, preferably
binding poly- and mono-unsaturated fatty acids as compared with
saturated ones. In parallel, using an in silico approach, we showed
conformational changes of the cavity and a shift in the tertiary
structure of Pru p 3 as a consequence of OLE and OLE2 binding.
Notably, the IgE ELISA performed with sera from 10 peach-
allergic patients confirmed our hypothesis that exposure of the
C-terminal loop due to the OLE/OLE2 binding could indeed
enhance the IgE-binding activity. In contrast, binding of STE
was unable to increase the IgE-binding capacity. This corrobo-
rates our idea that only those ligands that shift the tertiary struc-
ture of Pru p 3, thus exposing IgE epitopes, could increase its
allergenic potential. This observation is consistent with previous
studies indicating that no synthetic peptides covering areas of he-
lix 3 or loop 3 were identified among the most reactive peptides in
the SPOTanalysis, probably because most of this region is mainly
buried inside the compact 3-dimensional structure of Pru p 3.7
Consistent with the data obtained by ELISA, OLE, but not
STE, had a significant impact on the basophil activation. This is
in line with a study on grape nsLTP where the presence of phos-
phatidylcholine in an in vitro digestion assay had not only a pro-
tective effect on the allergen but also increased the ability of the
allergen to induce basophil histamine release and to elicit skin re-
actions in 4 patients with grape allergy.8 It becomes clear that
lipids, in addition to their role as direct immune modulators,
can influence the allergenicity of proteins9 by modifying the
allergen structure and biochemical properties. Among unsatu-
rated fatty acids, OLE is abundantly found in peach fruits, but it
is also endogenously present in the lipid bilayer of the humangut. Pru p 3 seems to be presented in its holoform to the allergic
individual throughout exposure and digestion. This, in turn, ex-
plains that this immunodominant B-cell epitope is conserved
and surface exposed. In this context, the application of Pru p 3
in diagnostic tests should be reconsidered, using Pru p 3 together
with OLE for component-resolved diagnosis to increase assay
sensitivity. Furthermore, for designing low allergenic Pru p 3 var-
iants for immunotherapy, the amino acid residues relevant for
OLE interaction are the targets for mutations and thus reduce
the risk of side effects during immunotherapy.
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METHODS
Chemicals and reagents
All reagents were purchased from Sigma-Aldrich (St Louis, Mo) unless
stated otherwise.
Purification of natural Pru p 3 and expression and
purification of rPru p 3
Natural Pru p 3 (nPru p 3) was extracted and purified frompeach (P persica)
peel as previously described by Gaier et al.E1 Briefly, the peel of 1 kg of peach
fruits was ground in liquid nitrogen and transferred in the extraction buffer
(46 mM sodium phosphate, 2 mM EDTA, 20 mM sodium diethyldithiocarba-
mate, 3 mMNaN3, 3% w/v PVPP, pH 7.0). The mixture was stirred for 1 hour
at 48C and then centrifuged (10,000g for 10 minutes, 48C). The supernatant
was precipitated with 95%w/v ammonium sulphate, resuspended, and filtered
through a 0.22mMfilter. nPru p 3was then purifiedwith cation exchange chro-
matography (Mono S column, GE Healthcare, Little Chalfont, United
Kingdom) followed by gel filtration (Superdex 200 column, GE Healthcare).
The recombinant counterpart of nPru p 3 was produced in the yeast Pichia
pastoris. The protein sequence ofmature Pru p 3 was retrieved fromGenebank
(Acc. no CAB96876) and optimization for P pastoris codon usage as well as
prediction of glycosylation sites was performed. The plasmid construct pPIC-
ZaA-Pru p 3 (ThermoFisher Scientific, Waltham, Mass) was linearized with
SacI (New England Biolabs, Ipswich, Miss) and used to transform GS115 P
pastoris cells (ThermoFisher Scientific) by electroporation. Transformed cells
were grown on yeast extract peptone dextrose medium plates containing
100mg/mL zeocin (Invivogen, SanDiego, Calif) at 288C for 5 days.Multicopy
screening was performed by replica plating of the positive cells on yeast
extract peptone dextrose with increasing zeocin concentration (up to
2000 mg/mL). Positive transformants expressing rPru p 3 with highest yield
were cultivated in 200 mL minimal glycerol medium containing histidine
for 1 day at 288C under shaking conditions until the culture reached an
OD600 value of 2 to 3. Cells were harvested and transferred to minimal
methanol 1 histidine medium (248C, 140 rpm), containing 1% of methanol
to induce protein expression. Methanol (at a final concentration of 1%) was
also added to the liquid culture every 12 hours. After 5 days of incubation,
the culture supernatant was collected by centrifugation (6000g for 20 minutes
at 48C) and stored at 2208C.
For subsequent purification, 200 mL of supernatant was dialyzed against
binding buffer (20 mM sodium acetate, pH 6.5). After filtration through a
0.22 mm filter, the protein solution was applied to a 1 mL Mono S column
(GEHealthcare). Bound proteins were eluted by a linear concentration gradient
of NaCl (0-0.5 mol/L) at a flow rate of 1 mL/min. In the second step, samples
containing protein of interest were applied on anRP-HPLC JupiterC5 analytical
column (Phenomenex, Torrance, Calif). The column was equilibrated with the
mobile phase (10% acetonitrile, 90% water, 0.1% trifluoroacetic acid) and
eluted by increasing concentration of acetonitrile (up to 50%) with flow rate
1 mL/min. nsLTP-containing fractions were analyzed by 15% SDS-PAGE and
the concentration of the purified rPru p 3 was determined using the
bicinchoninic acid assay according to the manufacturer’s protocol
(ThermoFisher Scientific). Samples were stored at 2208C.
Protein structure characterization
The N-terminal sequences of both recombinant and natural Pru p 3 were
determined using an Applied Biosystems Procise 491 sequencer (Applied
Biosystems, Foster City, Calif). Purified proteins (100 pmol) were adsorbed
onto a Prosorb cartridge and subjected to sequence analysis. For intact mass
determination, nonreduced protein samples of purified nPru p 3 and rPru p 3
were spotted in a ratio of 1:1 with matrix (a-cyano-4-hydroxycinnamic acid)
onto a ground steel matrix-assisted laser desorption & ionization target plate
and measured in linear mode on a matrix-assisted laser desorption &
ionization time-of-flight mass spectrometer (Microflex, Bruker Daltonics,
Bremen, Germany). Secondary structure analysis of purified Pru p 3 was
performed byCD spectroscopy (Jasco International Co., Hachioji, Tokyo). CD
spectra of natural and recombinant Pru p 3 were measured from 190 to 260 nm
at 258C and pH 7.5 using 10mM sodium phosphate buffer in 2-mmpath length
quartz cell. Spectra represent the average of 4 accumulations collected at
100 nm/min with a 2-second time constant, 0.5 nm resolution, and sensitivity
of 6100 mdeg. Spectra are represented as molar circular dichroism (with
respect to moles of amide bonds).
Lipid-binding assays
ANS displacement assay. The probe 1-anilinonaphthalene-8-sulfonic
acid (1,8-ANS) is nonfluorescent in water but fluorescent when binding to the
hydrophobic cavity of Pru p 3, with a maximum emission wavelength at
456 nm. Natural and recombinant Pru p 3 (10mM)were incubated overnight at
48C with different ligands: 3 unsaturated fatty acids, OLE (C18:1), elaidic (or
trans-OLE; C18:1), and linoleic (C18:2), and 3 saturated fatty acids, stearic
(STE; C18:0), lauric (C12:0), and palmitic (C16:0), at the following molar
ratios: 1:1, 1:2, 1:5, and 1:10. In addition, to test whether the hydroxyl group
influences the binding of free fatty acids to Pru p 3, 16-hydroxypalmitic acid
(C16OH) was tested as described above. Binding of ligands was monitored by
adding 10 mM1,8-ANS and measuring the decrease in 1,8-ANS fluorescence.
All samples were analyzed in triplicate. Purified nPru p 3 with ANS and
ligands with ANS served as controls.
Water-ligand observed via gradient spectroscopy. As saturation-
transfer difference approach, W-LOGSY is based on a transient nuclear
Overhauser effect experiment, and implies transfer of magnetization via an
intermolecular nuclear Overhauser effect and spin diffusion. Nonbinders and
binders are easily discriminated from each other because they giveW-LOGSY
signals of opposite sign.E2 W-LOGSY NMR experiments were acquired for
OLE and STE dissolved in H2O with 10% (v/v) of (CD3)2SO (hexadeuterodi-
methyl sulfoxide). rPru p 3 stock solution was prepared in 20 mM sodium ac-
etate buffer, pH 6.5, containing 0.1 mol NaCl/D2O 9:1. The allergen was
mixed with tested ligands at a molar ratio of 1:20, to a final protein concentra-
tion of 5 mM. High-resolution NMR experiments were carried out using an
Avance 700 Bruker spectrometer equipped with a cryo probe, operating at a
proton resonance frequency of 700 MHz (11.7 Tesla) at 298 K. The experi-
ments were performed with a 1808 inversion pulse applied over the water
signal at approximately 4.7 ppm by means of a Gaussian-shaped selective
pulse of 10 ms. Each W-LOGSY spectrum was acquired with 512 scans.
Molecular dynamic analysis
Initial coordinates of Pru p 3 were taken from PDB:2B5S, and the AMBER
force field ff03.r1 was applied to the protein. Molecular force fields of OLE
and its anion (OLE2) were described with the general AMBER force field. Li-
gands were first optimized in extended conformations in vacuum at the
B3LYP/6-31G(d,p) level and then the electrostatic potential around them
was computed at the level that is consistent with the general AMBER force
field, that is, HF/6-31G(d). Quantum chemical computations were performed
with Gaussian 09 suite of programs.E3 From the electrostatic potential RESP
atomic charges were fitted with the use of antechamber and RESP programs
from the AmberTools package.E4 The ionization state of Pru p 3 residues
was tested with the PROPKA 3.1 software and for pH 7 all residues were pre-
dicted to be in their standard ionization state (N- and C-termini all LYS, ARG,
and ASP charged). The N-terminal Met residue of the Pru p 3 structure was
removed, as it was added to the protein because of its heterologous expression
in a bacterial host. The protein moleculewas subsequently placed in a periodic
box filled with explicit water molecules described with the TIP3P model and
appropriate number of chloride anions (7 for the unliganded protein and its
complex with OLE, 6 for the Pru p 3/OLE2 complex) to obtain a charge-
neutral system. Size of the box was such that its edge was 10 A away from
the protein surface in each direction. The system was first minimized in 3
steps: 5,000 steps with protein atoms restrained with 500 kcal/mol A2 har-
monic constant; 5,000 steps with 10 kcal/mol A2 harmonic restraint on pro-
tein; and then 10,000 steps of an unrestrained minimization. After
minimization, the system was heated up from 0 to 300 K during a 50 ps NV
dynamics and then its density was equilibrated in a 0.5 ns NPT dynamics. Sub-
sequent unrestrained NPT (T 5 300 K, P 5 1 atm) production dynamics
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simulation spanned 150 ns for each system, with a snapshot saved every 10 ps.
Integration time step used in molecular dynamics simulations was 2 fs. The
SHAKE algorithm was used to constrain bonds of hydrogen atoms, and
temperature and pressure were controlled with the Langevin dynamics and
isotropic position scaling algorithm, respectively. Snapshots of the last
10 ns of simulations were clusteredwith the average linkage algorithm applied
to Ca carbons of the protein backbone. Representative structures of
dominating clusters were used for structure comparisons.
Patients
Serum samples were obtained from a well-defined group of 10 peach-
allergic patients (7 females and 3 males with a mean age of 29.7 years) and 4
controls from nonatopic donors. The study was approved by the Ethic
Committee of the Medical University of Vienna (EK1263/2014), and written
informed consent was obtained from all subjects. Peach-specific and Pru p 3–
specific IgE values were evaluated by means of CAP/RAST (ThermoFisher,
Uppsala, Sweden). IgE values and clinical symptoms to peach of all patients
are summarized in Table E1. After consumption of peach, all patients devel-
oped systemic reactions, such as urticaria, angioedema, or rhinitis and some
of them also suffered from oral allergy syndrome. In addition, all patients
positively responded to skin prick test with commercial peach extract as
well as to prick-to-prick test with fresh peaches.
IgE ELISA
To ensure the binding of the protein in the native state to the ELISA plate,
Thermo Scientific Nunc Immobilizer Amino surface plates were used. Twenty
micrograms of rPru p 3 (2 mM) in 100 mM sodium carbonate, pH 9.6, was
incubated at room temperature for 1 hour to enable reaction with amine and
thiol functions. After coupling to the surface, remaining Nunc Immobilizer
electrophilic groups were quenched by reaction with 10 mM ethanolamine.
A total of 60 mM of OLE or STE was added and incubated overnight with
protein at 48C. Subsequent steps were performed as described previously.E1 As
REFERENCES
E1. Gaier S, Marsh J, Oberhuber C, Rigby NM, Lovegrove A, Alessandri S, et al. Pu-
rification and structural stability of the peach allergens Pru p 1 and Pru p 3. Mol
Nutr Food Res 2008;52:S220-9.
E2. Dalvit C, Fogliatto G, Stewart A, Veronesi M, Stockman B. WaterLOGSY as a
method for primary NMR screening: practical aspects and range of applicability.
J Biomolecular NMR 2001;21:349-59.
E3. Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR,
et al. Gaussian 09, Revision E.01. Wallingford, CT: Gaussian, Inc; 2016.
E4. Case DA, Darden TA, Cheatham TE, Simmerling CL, Wang J, Duke RE, et al.
AMBER 12. San Francisco: University of California; 2012.
E5. Santos AF, James LK, Bahnson HT, Shamji MH, Couto-Francisco NC, Islam S,
et al. IgG4 inhibits peanut-induced basophil and mast cell activation in peanut-
tolerant children sensitized to peanut major allergens. J Allergy Clin Immunol
2015;135:1249-56.
negative controls, normal human serum, STE, and OLE, respectively, were
tested in parallel; the mean value of the negative controls was subtracted.
Basophil activation test assay
PBMCs were isolated from peripheral blood of non–peach-sensitized
donors by density gradient separation with Ficoll-Hypaque (ThermoFisher).
Receptor-bound IgE was removed from basophils by incubation in lactic acid
(pH 3.9) as previously described.E5 Stripped basophils were then passively
sensitized by incubation in human serum from 6 peach-sensitized donors for
60 minutes at 378C. Subsequently, they were stimulated with titrated concen-
trations of rPru p 3 (10 mg/mL, 1 mg/mL, 100 ng/mL, 1 ng/mL, 100 pg/mL,
1 pg/mL, 0.1 pg/mL) that had been incubated with different dilutions of
STEorOLE (ratio 1:1, 1:5, 1:10, 1:100) overnight at 48C. The ratio of protein:-
ligand (1:10) with a final rPru p 3 concentration of 1 ng/mL or 1 mg/mL was
selected after preliminary optimization, and only these data are shown.
Basophils were labeled with CCR3 (eBioscience, Santa Clara, Calif) and
CD123 (Biolegend, San Diego, Calif) and their activation was presented as
percentage of CD631 basophils.
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FIG E1. Comparison of purified nPru p 3 and rPru p 3.A, Coomassie stained
15% SDS-PAGE. B, Matrix-assisted laser desorption & ionization time-of-
flight mass spectrum analysis. C, Amino acid sequences. Cysteines,
responsible for disulfide bonds, are marked in red; additional residues
from P pastoris cleavage marked in green; N-terminal amino acid residues
verified by sequencing are underlined. D, Far-ultraviolet circular dichroism
spectra. Intens., Intensity.
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FIG E2. Pru p 3 displays differential ligand binding. 1-Dimensional W-
LOGSY spectrum of 80 mM OLE and STE alone (upper), in the presence of
Pru p 3 (8 mM) (middle); 1-Dimensional 1H spectrum of OLE and STE
(lower).
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FIG E3. RMSD versus time plot for molecular dynamic simulation A, Pru p
3–OLE2 complex; B, Pru p 3–OLE complex. RMSD, Root-mean-square devi-
ation of atomic positions.
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FIG E4. Intermolecular contacts in Pru p 3-OLE2 (A) and Pru p 3-OLE (B)
complex from molecular dynamic simulation (10-150 ns). Color code
from red (most frequent contacts), through green to blue (no contacts). Pro-
tein residues making most contacts are labeled.
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FIG E5. Superimposed structures of Pru p 3-OLE2 (in blue) and Pru p 3-OLE
(in orange/yellow) complexes.
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TABLE E1. Clinical data of the patient population
Patient no. Sex Age (y)
IgE (kU/L) specific
for:
Symptoms to peach* Other sensitizations*
OAS URT AE RHIN Respiratory FoodPeach Pru p 3
1 Female 16 44.0 54.0 1 1 G eg, le, to
2 Female 23 26.0 29.6 1 1 A, J le, me, to, wa
3 Female 44 0.8 3.1 1 1 G ar, le, to, wa
4 Male 14 13.5 4.2 1 G, J, M —
5 Male 46 0.6 0.5 1 1 G, J, M, O ap, ha, pe
6 Male 30 2.9 1.3 1 J, T, O ha
7 Female 26 6.4 4.0 1 G, T f
8 Female 41 0.8 0.4 1 J —
9 Female 26 4.8 6.8 1 1 A, D, G, J, M ha, le, or, to
10 Female 31 7.5 1.9 1 G ha, eg, pn
AE, Angioedema; OAS, oral allergy syndrome; RHIN, rhinitis; URT, urticaria.
*G, Grasses; eg, eggplant; le, lettuce; to, tomato; A, Alternaria species; J, cypress; me, melon; wa, walnut; ar, apricot; M, mugwort; O, olive; ap, apple; ha, hazelnut; pe, pear; T,
plane; f, fish; D, mites; or, orange; pn, peanuts.
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TABLE E2. Pru p 3 displays differential ligand binding
Ligand
ANS fluorescence reduction (%)
10 mM 20 mM 50 mM 100 mM
LAU (C12:0) 30.6 41.6 58.5 66.5
PAL (C16:0) 45.9 58.9 59.3 58.8
HYD (C16-OH) 25.0 41.4 49.7 51.1
STE (C18:0) 27.0 14.6 34.4 39.1
OLE (C18:1) 56.5 74.1 73.9 72.6
ELA (C18:1) 41.2 62.5 68.1 68.6
LIN (C18:2) 52.2 70.4 76.9 72.0
Concentration-dependent reduction in ANS binding to Pru p 3 preincubated with free fatty acid.
ELA, Elaidic acid; HYD, 16-hydroxypalmitic acid; LAU, lauric acid; LIN, linoleic acid; PAL, palmitic acid.
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TABLE E3. Impact of interaction between free fatty acids and Pru p 3 on IgE binding and basophil activation
Patient serum no.
ELISA BAT
Pru p 3 1 OLE Pru p 3 1 STE Pru p 3 1 OLE Pru p 3 1 STE
1 142.57 154.69 16.50 21.30
2 1117.86 12.64 115.70 21.50
3 172.41 13.10 119.00 25.10
4 154.47 118.60 19.40 15.20
5 123.17 24.81 16.00 20.80
6 189.28 168.23 116.50 15.20
7 123.97 19.93
8 154.13 11.29
9 176.40 21.43
10 157.96 239.28
BAT, Basophil activation test.
Values in the table correspond to differences in % between Pru p 3 preincubated with OLE or STE and Pru p 3 alone. (1) upregulation, (2) downregulation.
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